Liver News and Research

RSS

New program targets cancers affecting the liver and bile ducts

Cancers affecting the liver and bile ducts will be the target of a new program at Perlmutter Cancer Center at NYU Langone Health to provide multidisciplinary clinical care and rapidly bring important new research to the clinic.

7 Nov 2017

New category of immunotherapy appears safe to use in patients with both cancer and HIV

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.

7 Nov 2017

SLU researcher reports success in identifying new drug targets for muscular dystrophy

In a recent paper published in the journal Skeletal Muscle, a Saint Louis University researcher reports success in identifying new drug targets that potentially could slow or halt the progression of a form muscular dystrophy, an illness characterized by progressive muscle degeneration.

7 Nov 2017

Australia’s annual report on STIs shows increasing rates of gonorrhea and syphilis

Cases of gonorrhea and syphilis are increasing in Australia, according to the most recent Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible infections (STIs) in Australia.

7 Nov 2017

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Research at the Southwest National Primate Research Center on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

Fat hormone associated with NASH may be effective target for therapeutic intervention

The rising obesity epidemic has brought with it an army of maladies. One, in particular, is threatening to outpace many of the disorders that accompany obesity, in terms of occurrence and severity: nonalcoholic fatty liver disease.

7 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

NIH awards grant to test whether anti-inflammatory diet can reduce Alzheimer's disease risk

The National Institutes of Health has awarded Albert Einstein College of Medicine nutrition scientist Yasmin Mossavar-Rahmani, Ph.D., R.D., a five-year, $4 million grant to test whether a diet rich in foods with anti-inflammatory properties can reduce cognitive decline and Alzheimer's disease risk.

6 Nov 2017

Researchers discover how traffic jam in intracellular sorting can cause tumor development

For tissues to cooperate and perform normal functions, cells need to know which way is up. When cells lose track of their orientation, they can start to grow out of control, and develop into cancer.

6 Nov 2017

Gonorrhea and syphilis cases rise in Australia

The Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible infections (STIs) in Australia was released and it revealed that there is a rise in diagnosis of gonorrhea and syphilis but the number of people being affected by HIV has plateaued. In addition tens of thousands of people have been cured of Hepatitis C. The report comes from the Kirby Institute at UNSW Sydney.

5 Nov 2017

Gut bacteria composition could predict toxicity of chemotherapy drugs in cancer patients

Albert Einstein College of Medicine researchers report that the composition of people's gut bacteria may explain why some of them suffer life-threatening reactions after taking a key drug for treating metastatic colorectal cancer.

1 Nov 2017

Scientists make breakthrough by suppressing aflatoxin-producing fungus in groundnut

Scientists at the Donald Danforth Plant Science Center, in St. Louis, MO and their collaborators at the International Crops Research Institute for the Semi-Arid Tropics in Hyderabad, India, United States Department of Agriculture and Louisiana State University have made a significant research breakthrough by suppressing the aflatoxin-producing fungus in groundnut.

1 Nov 2017

Cleveland Clinic researcher awarded $2.6 million grant to create innovative models of colorectal cancer

Cleveland Clinic researcher Emina Huang, M.D., a colorectal surgeon in the Digestive Disease and Surgery Institute and a staff member in the Lerner Research Institute's Department of Stem Cell Biology and Regenerative Medicine, has been awarded a collaborative five-year, $2.6 million grant from the National Cancer Institute to create innovative models of colorectal cancer that will enhance understanding of how the disease develops and spreads.

31 Oct 2017

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced US$16.7 million to support development of new compounds for fighting malaria and tuberculosis, a leishmaniasis vaccine and drug, and a treatment for a long-ignored flesh-eating infection.

31 Oct 2017

Researchers develop illuminated pajamas for babies being treated for jaundice

Alone, naked, and with their eyes covered for protection: this is how newborns lie in incubators when they are being treated for jaundice. Irradiation with blue light in an incubator is necessary because toxic decomposition products of the blood pigment hemoglobin are deposited in the skin in newborns with jaundice.

31 Oct 2017

Alzheimer's disease could be triggered by breakdowns from other parts of the body

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scientists indicates that it could be triggered by breakdowns elsewhere in the body.

31 Oct 2017

University of Pittsburgh research collaboration works toward saving more organs for transplants

Each year, the United States suffers an extreme shortage of organ donations, with only a quarter of patients in need receiving a transplant. Many transplantable organs are lost when a donor's heart fails, and the organs stop receiving vital blood flow.

31 Oct 2017

Canadian and Israeli researchers join forces for new research program

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.

30 Oct 2017

New discovery challenges basic assumptions about the brain's cellular makeup

A discovery made by Junhwan Kim, PhD, assistant professor at The Feinstein Institute for Medical Research, is challenging science's longstanding beliefs regarding the cellular makeup of the brain. This breakthrough was outlined in a study recently published in the journal Molecular and Cellular Biochemistry.

30 Oct 2017

Liver News and Research

New program targets cancers affecting the liver and bile ducts

New category of immunotherapy appears safe to use in patients with both cancer and HIV

SLU researcher reports success in identifying new drug targets for muscular dystrophy

Australia’s annual report on STIs shows increasing rates of gonorrhea and syphilis

Texas Biomedical Research Institute tests promising new treatment for HBV infection

FDA grants approval to first treatment for rare blood cancer

Fat hormone associated with NASH may be effective target for therapeutic intervention

FDA approves new drug Zelboraf for Erdheim-Chester disease

NIH awards grant to test whether anti-inflammatory diet can reduce Alzheimer's disease risk

Researchers discover how traffic jam in intracellular sorting can cause tumor development

Gonorrhea and syphilis cases rise in Australia

Gut bacteria composition could predict toxicity of chemotherapy drugs in cancer patients

Scientists make breakthrough by suppressing aflatoxin-producing fungus in groundnut

Cleveland Clinic researcher awarded $2.6 million grant to create innovative models of colorectal cancer

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

Researchers develop illuminated pajamas for babies being treated for jaundice

Alzheimer's disease could be triggered by breakdowns from other parts of the body

University of Pittsburgh research collaboration works toward saving more organs for transplants

Canadian and Israeli researchers join forces for new research program

New discovery challenges basic assumptions about the brain's cellular makeup

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News